CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
How do we trade off benefits and harms of anticancer drugs for advanced cancer patients?
Do Yeun Kim
J Korean Med Assoc. 2023;66(2):86-90.   Published online February 10, 2023

Excel Download

How do we trade off benefits and harms of anticancer drugs for advanced cancer patients?
Journal of the Korean Medical Association. 2023;66(2):86-90   Crossref logo
Link1 Link2 Link3

How do cancer screening guidelines trade off benefits versus harms and burdens of screening? A systematic survey
BMJ Open. 2020;10(12):e038322   Crossref logo

LDL Cholesterol Goals in High-Risk Patients: How Low Do We Go and How Do We Get There?
Drugs. 2013;73(4):293-301   Crossref logo
Link1 Link2 Link3

Risks and benefits of anticancer drugs in advanced cancer patients: A systematic review and meta-analysis
EClinicalMedicine. 2021;40:101130   Crossref logo
Link1 Link2

44: The benefits of precision medicine will require us to examine both what we do and how we do it
European Journal of Cancer. 2014;50:S12   Crossref logo
Link1 Link2

Gender Pay Gaps, the U.K. Experience: How Do We Close Them, How Do We Bring Research Into Practice?
Compensation & Benefits Review. 2019;51(4):144-161   Crossref logo
Link1 Link2 Link3

Weighing up the benefits and harms of a new anti-cancer drug: a survey of Australian oncologists
Internal Medicine Journal. 2015;45(8):834-842   Crossref logo
Link1 Link2

How do we increase quality of life for patients with dyspnoea suffering from advanced cancer, by using patient education
European Journal of Cancer. 2001;37:S433-S434   Crossref logo
Link1 Link2

Access to anticancer drugs: many evidence-based treatments are off-label and unfunded by the Pharmaceutical Benefits Scheme
Internal Medicine Journal. 2012;42(11):1224-1229   Crossref logo
Link1 Link2

The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups?
Quality of Life Research. 1994;3(4):257-265   Crossref logo
Link1 Link2 Link3